GCM
SRDX

Graham Capital Management’s Surmodics SRDX Stock Holding History

Graham Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,328
Closed -$440K – 1285
2023
Q1 		$440K Buy
+19,328
New +$498K 0.01% 778

Other funds holding SRDX

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Graham Capital Management's SRDX Position: Q2 2023 in Review

Graham Capital Management sold out of Surmodics (SRDX) in Q2 2023, closing a stake of 19,328 shares — an estimated $440K sold.

Graham Capital Management first reported a position in SRDX in Q1 2023 and held it in 1 quarter. The position peaked at $440K in Q1 2023. 105 funds tracked by Wall St. Rank hold SRDX as of Q2 2023.

  • Graham Capital Management reported no remaining Surmodics position as of Q2 2023 after selling out during the quarter.
  • Graham Capital Management sold 19,328 Surmodics shares in Q2 2023, an estimated $440K.
  • Graham Capital Management first reported a position in Surmodics in Q1 2023 and held it in 1 quarter.
  • Graham Capital Management's Surmodics position peaked at $440K in Q1 2023.
  • 105 funds tracked by Wall St. Rank held Surmodics as of Q2 2023.

Based on Graham Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.